公开(公告)号：US09008765B2

公开(公告)日：2015-04-14

申请号：US13466116

申请日：2012-05-07

申请人： Mir Imran ,  Talat Imran ,  Mir Hashim

发明人： Mir Imran ,  Talat Imran ,  Mir Hashim

IPC分类号： A61N1/30 ,  A61K9/00 ,  A61N1/04 ,  A61N1/32 ,  A61K31/465

CPC分类号： A61N1/30 ,  A61K9/0009 ,  A61K9/0014 ,  A61K31/465 ,  A61N1/0432 ,  A61N1/0448 ,  A61N1/303 ,  A61N1/325

摘要： Embodiments of the invention provide methods for the transdermal delivery of therapeutic agents for the treatment of addictive cravings e.g., nicotine compounds for the treatment of nicotine cravings from tobacco use. An embodiment of a method for such delivery comprises positioning at least one electrode assembly in electrical communication with a patient's skin. The assembly includes a solution comprising a therapeutic agent which passively diffuses into the skin. A dose of agent is delivered from the assembly into the skin during a first period using a first current having a characteristic e.g., polarity and magnitude, to repel the agent out of the assembly. During a second period, a second current having a characteristic to attract the agent is used to retain the agent in the assembly such that delivery of agent into skin is minimized. A dose of agent may be delivered on demand by an input from the patient.

摘要翻译： 本发明的实施方案提供了用于治疗成瘾性渴望的治疗剂的透皮递送方法，例如用于治疗来自烟草使用的尼古丁渴望的尼古丁化合物。 用于这种传送的方法的实施例包括将至少一个电极组件定位成与患者的皮肤电连通。 组合件包括包含被动地扩散入皮肤的治疗剂的溶液。 使用具有例如极性和大小的特性的第一电流，在第一时段期间，将剂量的药剂从组合物输送到皮肤中，以将药剂排斥出组合体。 在第二时段期间，使用具有吸引剂的特性的第二电流来将药剂保持在组合中，使得药剂递送到皮肤中最小化。 可以根据患者的输入要求递送剂量。

公开(公告)号：US20130023850A1

公开(公告)日：2013-01-24

申请号：US13466116

申请日：2012-05-07

申请人： Mir Imran ,  Talat Imran ,  Mir Hashim

发明人： Mir Imran ,  Talat Imran ,  Mir Hashim

IPC分类号： A61N1/30

CPC分类号： A61N1/30 ,  A61K9/0009 ,  A61K9/0014 ,  A61K31/465 ,  A61N1/0432 ,  A61N1/0448 ,  A61N1/303 ,  A61N1/325

摘要： Embodiments of the invention provide methods for the transdermal delivery of therapeutic agents for the treatment of addictive cravings e.g., nicotine compounds for the treatment of nicotine cravings from tobacco use. An embodiment of a method for such delivery comprises positioning at least one electrode assembly in electrical communication with a patient's skin. The assembly includes a solution comprising a therapeutic agent which passively diffuses into the skin. A dose of agent is delivered from the assembly into the skin during a first period using a first current having a characteristic e.g., polarity and magnitude, to repel the agent out of the assembly. During a second period, a second current having a characteristic to attract the agent is used to retain the agent in the assembly such that delivery of agent into skin is minimized. A dose of agent may be delivered on demand by an input from the patient.

公开(公告)号：US09095503B2

公开(公告)日：2015-08-04

申请号：US13430662

申请日：2012-03-26

申请人： Mir Imran ,  Mir Hashim ,  Glen McLaughlin ,  Huma Arastu ,  Rekha Vaidyanathan ,  Joel Harris ,  Radhika Korupolu ,  Andrew Mangogna ,  Chang Ong ,  Sanjay Patel ,  Lu Wang ,  Timothy Williams

发明人： Mir Imran ,  Mir Hashim ,  Glen McLaughlin ,  Huma Arastu ,  Rekha Vaidyanathan ,  Joel Harris ,  Radhika Korupolu ,  Andrew Mangogna ,  Chang Ong ,  Sanjay Patel ,  Lu Wang ,  Timothy Williams

IPC分类号： A61N1/30 ,  A61K9/00 ,  A61N1/04 ,  A61K31/4178 ,  A61K31/4468 ,  A61K31/454 ,  A61K31/5415 ,  A61N1/32

CPC分类号： A61N1/325 ,  A61K9/0009 ,  A61K9/0014 ,  A61K31/4178 ,  A61K31/4468 ,  A61K31/454 ,  A61K31/5415 ,  A61N1/0436 ,  A61N1/044 ,  A61N1/0448 ,  A61N1/30 ,  A61N1/303

摘要： Various embodiments provide methods and systems for the biphasic iontophoretic transdermal delivery of therapeutic agents. An embodiment of a method for such delivery comprises positioning at least one electrode assembly in electrical communication with a patient's skin. The assembly includes a solution comprising a therapeutic agent which passively diffuses into the skin. A dose of agent is delivered from the assembly into the skin during a first period using a first current having a characteristic e.g., polarity and magnitude, to repel the agent out of the assembly. During a second period, a second current having a characteristic to attract the agent is used to retain the agent in the assembly such that delivery of agent into skin is minimized. A dose of agent may be delivered on demand by an input from the patient. Embodiments may be used for delivery of agents which cause adverse effects from unwanted passive diffusion.

摘要翻译： 各种实施方案提供了用于治疗剂的双相离子电渗透皮递送的方法和系统。 用于这种传送的方法的实施例包括将至少一个电极组件定位成与患者的皮肤电连通。 组合件包括包含被动地扩散入皮肤的治疗剂的溶液。 使用具有例如极性和大小的特性的第一电流，在第一时段期间，将剂量的药剂从组合物输送到皮肤中，以将药剂排斥出组合体。 在第二时段期间，使用具有吸引剂的特性的第二电流将试剂保持在组合中，使得药剂递送到皮肤中最小化。 可以根据患者的输入要求递送剂量。 实施方案可以用于递送由不希望的被动扩散引起不利影响的试剂。

公开(公告)号：US20120184894A1

公开(公告)日：2012-07-19

申请号：US13342948

申请日：2012-01-03

申请人： Mir Imran ,  Phil Morgan ,  Mir Hashim ,  Joel Harris

发明人： Mir Imran ,  Phil Morgan ,  Mir Hashim ,  Joel Harris

IPC分类号： A61N1/30

CPC分类号： A61K8/0208 ,  A61K8/19 ,  A61K9/0009 ,  A61K9/0021 ,  A61K9/7046 ,  A61K33/26 ,  A61K33/42 ,  A61K2800/83 ,  A61Q7/00

摘要： Embodiments of the invention provide patches for the transdermal delivery of compositions to treat an individual suffering from hair loss. Many embodiments provide an iontophoretic patch for the transdermal delivery hair growth stimulating agents for the treatment of hair loss by stimulating the growth of new hair in areas of the scalp exhibiting hair loss. The patch comprises an electrode and a reservoir containing a composition comprising iron containing compound, such as a chelated iron compound for the delivery of the therapeutically effective amount of iron. The patch can be shaped to be placed and remain on the head. Various embodiments provide methods of using embodiments of the iontophoretic patch for delivering a hair growth stimulating agent such as a chelated iron compound, minoxidil and finasteride to the scalp and other areas exhibiting hair loss. Such methods can be used for re-growing hair, and/or preventing or slowing hair loss.

摘要翻译： 本发明的实施方案提供了用于透皮递送组合物以治疗患有脱发的个体的贴剂。 许多实施方案提供用于透皮递送毛发生长刺激剂的离子电渗贴剂，用于通过在头皮表现出脱发的区域中刺激新毛发的生长来治疗脱发。 贴片包括电极和储存器，其含有包含含铁化合物的组合物，例如用于递送治疗有效量的铁的螯合铁化合物。 该贴片的形状可被放置并保留在头部上。 各种实施方案提供了使用离子电渗贴剂的实施方案将头发生长刺激剂如螯合铁化合物，米诺地尔和非那雄胺递送至头皮和其它出现脱发的区域的方法。 这种方法可用于再生长毛发和/或预防或减缓脱发。

公开(公告)号：US08821945B2

公开(公告)日：2014-09-02

申请号：US12459862

申请日：2009-07-07

申请人： Mir Imran ,  Mir Hashim ,  Sanjay Patel ,  Ronald J. Berenson

发明人： Mir Imran ,  Mir Hashim ,  Sanjay Patel ,  Ronald J. Berenson

IPC分类号： A01N59/16 ,  A01N59/26 ,  A61N1/30

CPC分类号： A61K41/0047 ,  A61K9/0009 ,  A61K9/703 ,  A61K9/7084 ,  A61K33/26 ,  A61K33/42 ,  A61K41/00 ,  A61N1/0496 ,  A61N1/30 ,  A61N1/325

摘要： Embodiments provide devices, systems and methods for the transdermal delivery of chelated compounds. One embodiment provides a method for the iontophoretic transdermal delivery of a chelated iron complex for the treatment of anemia. A first patch comprising an active electrode and a chelated iron complex is applied to the skin; a second patch containing an electrode is also applied. An electrical current is then delivered to the skin from the active electrode. The chelated complex is transported across the skin via electromotive force from the current, with the iron being substantially chromogenically unreactive with the skin during transport so that there is little or no tattooing of the skin due to the formation of insoluble oxidative products. The complex is then dissociated by phagocytosis or related process to release the iron where it may be bound by transferrin or ferritin and carried to other sites for storage or metabolic use.

摘要翻译： 实施方案提供用于经皮递送螯合化合物的装置，系统和方法。 一个实施方案提供了用于治疗贫血的螯合铁络合物的离子电渗疗法透皮递送的方法。 将包含活性电极和螯合铁络合物的第一贴片施加到皮肤上; 还应用了包含电极的第二贴片。 然后从活性电极将电流输送到皮肤。 螯合络合物通过电流从电流传递穿过皮肤，铁在运输过程中与皮肤基本上不发生色素反应，因此由于不溶性氧化产物的形成，皮肤几乎或没有纹身。 然后通过吞噬作用或相关过程解离复合物以释放铁，其中它可被转铁蛋白或铁蛋白结合并携带到其它部位用于储存或代谢使用。

公开(公告)号：US20180037643A9

公开(公告)日：2018-02-08

申请号：US15150379

申请日：2016-05-09

申请人： Mir Imran ,  Radhika Korupolu ,  Elaine To ,  Mir Hashim

发明人： Mir Imran ,  Radhika Korupolu ,  Elaine To ,  Mir Hashim

IPC分类号： C07K16/24 ,  A61M25/10

CPC分类号： C07K16/244 ,  A61K38/26 ,  A61K38/28 ,  A61M25/10 ,  A61M2025/105 ,  C07K16/2866 ,  C07K2317/24 ,  C07K2317/76

摘要： Embodiments of the invention provide swallowable devices, preparations and methods for delivering therapeutic agents within the GI tract such as neutralizing proteins (NP) particularly antibodies which neutralize interleukins. Many embodiments provide a swallowable device e.g., a capsule for delivering various agents into the intestinal wall (IW). Embodiments also provide agent preparations that are configured to be contained within the capsule, advanced from the capsule into the IW and degrade to release the agent into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW. Embodiments of the invention are particularly useful for the delivery of interleukin NP's (INP) for treatment of inflammatory conditions where such INP's are poorly absorbed, tolerated and/or degraded within the GI tract.

公开(公告)号：US20180251537A9

公开(公告)日：2018-09-06

申请号：US15150379

申请日：2016-05-09

申请人： Mir Imran ,  Radhika Korupolu ,  Elaine To ,  Mir Hashim

发明人： Mir Imran ,  Radhika Korupolu ,  Elaine To ,  Mir Hashim

IPC分类号： C07K16/24 ,  A61M25/10

CPC分类号： C07K16/244 ,  A61K38/26 ,  A61K38/28 ,  A61M25/10 ,  A61M2025/105 ,  C07K16/2866 ,  C07K2317/24 ,  C07K2317/76

摘要： Embodiments of the invention provide swallowable devices, preparations and methods for delivering therapeutic agents within the GI tract such as neutralizing proteins (NP) particularly antibodies which neutralize interleukins. Many embodiments provide a swallowable device e.g., a capsule for delivering various agents into the intestinal wall (IW). Embodiments also provide agent preparations that are configured to be contained within the capsule, advanced from the capsule into the IW and degrade to release the agent into the bloodstream to produce a therapeutic effect. The preparation can be operably coupled to delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW. Embodiments of the invention are particularly useful for the delivery of interleukin NP's (INP) for treatment of inflammatory conditions where such INP's are poorly absorbed, tolerated and/or degraded within the GI tract.

公开(公告)号：US20130023815A1

公开(公告)日：2013-01-24

申请号：US13430662

申请日：2012-03-26

申请人： Mir Imran ,  Mir Hashim ,  Glen McLaughlin ,  Huma Arastu ,  Rekha Vaidyanathan ,  Joel Harris ,  Radhika Korupolu ,  Andrew Mangogna ,  Chang Ong ,  Sanjay Patel ,  Lu Wang ,  Timothy Williams

发明人： Mir Imran ,  Mir Hashim ,  Glen McLaughlin ,  Huma Arastu ,  Rekha Vaidyanathan ,  Joel Harris ,  Radhika Korupolu ,  Andrew Mangogna ,  Chang Ong ,  Sanjay Patel ,  Lu Wang ,  Timothy Williams

IPC分类号： A61N1/30

CPC分类号： A61N1/325 ,  A61K9/0009 ,  A61K9/0014 ,  A61K31/4178 ,  A61K31/4468 ,  A61K31/454 ,  A61K31/5415 ,  A61N1/0436 ,  A61N1/044 ,  A61N1/0448 ,  A61N1/30 ,  A61N1/303

摘要： Various embodiments provide methods and systems for the biphasic iontophoretic transdermal delivery of therapeutic agents. An embodiment of a method for such delivery comprises positioning at least one electrode assembly in electrical communication with a patient's skin. The assembly includes a solution comprising a therapeutic agent which passively diffuses into the skin. A dose of agent is delivered from the assembly into the skin during a first period using a first current having a characteristic e.g., polarity and magnitude, to repel the agent out of the assembly. During a second period, a second current having a characteristic to attract the agent is used to retain the agent in the assembly such that delivery of agent into skin is minimized. A dose of agent may be delivered on demand by an input from the patient. Embodiments may be used for delivery of agents which cause adverse effects from unwanted passive diffusion.

公开(公告)号：US20100272827A1

公开(公告)日：2010-10-28

申请号：US12459862

申请日：2009-07-07

申请人： Mir Imran ,  Mir Hashim ,  Sanjay Patel ,  Ronald J. Berenson

发明人： Mir Imran ,  Mir Hashim ,  Sanjay Patel ,  Ronald J. Berenson

IPC分类号： A61K33/42 ,  A61K33/26 ,  A61P7/06

CPC分类号： A61K41/0047 ,  A61K9/0009 ,  A61K9/703 ,  A61K9/7084 ,  A61K33/26 ,  A61K33/42 ,  A61K41/00 ,  A61N1/0496 ,  A61N1/30 ,  A61N1/325

摘要： Embodiments provide devices, systems and methods for the transdermal delivery of chelated compounds. One embodiment provides a method for the iontophoretic transdermal delivery of a chelated iron complex for the treatment of anemia. A first patch comprising an active electrode and a chelated iron complex is applied to the skin; a second patch containing an electrode is also applied. An electrical current is then delivered to the skin from the active electrode. The chelated complex is transported across the skin via electromotive force from the current, with the iron being substantially chromogenically unreactive with the skin during transport so that there is little or no tattooing of the skin due to the formation of insoluble oxidative products. The complex is then dissociated by phagocytosis or related process to release the iron where it may be bound by transferrin or ferritin and carried to other sites for storage or metabolic use.

摘要翻译： 实施方案提供用于经皮递送螯合化合物的装置，系统和方法。 一个实施方案提供了用于治疗贫血的螯合铁络合物的离子电渗疗法透皮递送的方法。 将包含活性电极和螯合铁络合物的第一贴片施加到皮肤上; 还应用了包含电极的第二贴片。 然后从活性电极将电流输送到皮肤。 螯合络合物通过电流从电流传递穿过皮肤，铁在运输过程中与皮肤基本上不发生色素反应，因此由于不溶性氧化产物的形成，皮肤几乎或没有纹身。 然后通过吞噬作用或相关过程解离复合物以释放铁，其中它可被转铁蛋白或铁蛋白结合并携带到其它部位用于储存或代谢使用。

公开(公告)号：US09795296B2

公开(公告)日：2017-10-24

申请号：US13457456

申请日：2012-04-26

申请人： Mir Imran

发明人： Mir Imran

IPC分类号： A61B5/1455 ,  A61B5/00 ,  A61B5/08 ,  B63C11/26 ,  B63C11/18

CPC分类号： A61B5/0002 ,  A61B5/0816 ,  A61B5/14551 ,  A61B5/6803 ,  A61B5/682 ,  A61B2562/0204 ,  A61B2562/0238 ,  B63C11/186 ,  B63C11/26

摘要： Embodiments of the invention provide a system, apparatus and methods for measurement of biometric data of a diver. In many embodiments, the system includes a mouthpiece having a sensor device comprising a light emitter and detector configured to emit and detect light at a wavelength having an absorbance correlated with a level of a blood gas saturation e.g., oxygen, nitrogen, CO2. The emitter is positioned to emit light onto oral tissue of the diver and the detector positioned to detect light which is received from the oral tissue either by transmittance of light through the oral tissue or by reflection of light from the tissue. The target oral tissue can include one or both of gum or buccal tissue. Such embodiments allow data to be collected without having to wear additional sensors or measurement devices and allow for measurement of blood gas levels as the diver breaths through their mouthpiece.